Related Experiment Video
Updated: Mar 24, 2026

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
Clinical Challenges in Catecholaminergic Polymorphic Ventricular Tachycardia
Jacopo F Imberti1, Katherine Underwood1, Andrea Mazzanti1
1Molecular Cardiology, IRCCS Salvatore Maugeri Foundation, Pavia, Italy.
Insights
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a genetic heart condition causing sudden death. Research highlights challenges in CPVT diagnosis, prevalence, and treatment, necessitating new approaches.
Area of Science:
- Cardiology
- Genetics
- Electrophysiology
Background:
- Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited arrhythmia syndrome.
- It is a significant cause of sudden cardiac death in young individuals, often triggered by exercise or stress.
- Despite advancements, key aspects of CPVT remain poorly understood.
Purpose of the Study:
- To address the current knowledge gaps in the epidemiology, diagnosis, and management of CPVT.
- To highlight the challenges faced by cardiologists in managing CPVT patients.
- To emphasize the need for novel diagnostic, prognostic, and therapeutic strategies.
Main Methods:
- This review synthesizes current literature on CPVT.
- It analyzes epidemiological data, diagnostic challenges, and treatment outcomes.
- It discusses the limitations of existing diagnostic tools and therapeutic interventions.
Main Results:
- The true prevalence of CPVT is unknown and likely underestimated.
- Genetic testing confirms diagnosis in only about 50% of cases.
- A significant portion of CPVT patients experience persistent arrhythmias despite beta-blocker therapy.
Conclusions:
- CPVT diagnosis and management remain challenging for cardiologists.
- Further research is crucial to elucidate the role of emerging therapies like flecainide and left cardiac sympathetic denervation.
- Development of new diagnostic and therapeutic approaches is essential for improving outcomes in CPVT patients.
Abstract:
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inheritable cardiac disorder associated with exercise- and stress-induced sudden death in young individuals. Although important steps forward have been made in the comprehension and treatment of this disease, several aspects remain unclear. Firstly, from an epidemiological standpoint the actual prevalence of CPVT is still unknown and possibly underestimated. In addition, the diagnostic process remains very challenging and can be supported by genetic analysis in only about half of the cases. Finally, up to one third of CPVT patients continue to present complex arrhythmias despite beta blocker treatment; the role of newer therapeutic options, such as flecainide and left cardiac sympathetic denervation, needs to be further elucidated. All these points constitute challenges for the cardiologist in the management of CPVT patients and fuel research into new diagnostic, prognostic and therapeutic approaches.
More Related Videos
06:57Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
Published on: January 31, 2019
12:15Tissue Preparation Techniques for Contrast-Enhanced Micro Computed Tomography Imaging of Large Mammalian Cardiac Models with Chronic Disease
Published on: February 8, 2022
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias III: Characteristics of Dysrhythmias
Dysrhythmias II: Classification of Tachyarrhythmias
Increased pulse rate
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Cardiomyopathy II: Dilated Cardiomyopathy